Elevation Oncology Inc. (ELEV) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2, 3
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-01-18
4:00 pm
Purchase
2021-12-3113GElevation Oncology, Inc.
ELEV
Vertex Global HC Fund II Pte. Ltd.2,307,642
9.940%
2,307,642increase
(New Position)
Filing
History
2021-07-09
4:31 pm
Purchase
2021-06-2913GElevation Oncology, Inc.
ELEV
Boxer Capital LLC1,341,530
5.900%
1,341,530increase
(New Position)
Filing
History
2021-07-09
4:06 pm
Purchase
2021-06-2913GElevation Oncology, Inc.
ELEV
Cormorant Asset Management, LP1,983,168
8.690%
1,983,168increase
(New Position)
Filing
History
2021-07-09
4:01 pm
Purchase
2021-06-2913DElevation Oncology, Inc.
ELEV
venBio Global Strategic Fund III, L.P.2,608,167
11.430%
2,608,167increase
(New Position)
Filing
History
Goto Prev, 0, 1, 2, 3